Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quorum Sensing | 3 | 2023 | 8 | 1.780 |
Why?
|
| Bacteria | 3 | 2023 | 278 | 1.410 |
Why?
|
| Models, Biological | 6 | 2021 | 1143 | 1.380 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2022 | 540 | 1.310 |
Why?
|
| Wounds and Injuries | 5 | 2023 | 229 | 1.080 |
Why?
|
| Osteoporosis | 2 | 2025 | 102 | 1.080 |
Why?
|
| Accidents, Traffic | 6 | 2023 | 148 | 1.060 |
Why?
|
| Yeasts | 2 | 2020 | 51 | 1.000 |
Why?
|
| Bone Density Conservation Agents | 1 | 2025 | 44 | 0.940 |
Why?
|
| Ecosystem | 2 | 2022 | 38 | 0.920 |
Why?
|
| Temperature | 2 | 2023 | 295 | 0.820 |
Why?
|
| Embryonic Stem Cells | 1 | 2023 | 151 | 0.760 |
Why?
|
| Spores, Fungal | 1 | 2020 | 19 | 0.710 |
Why?
|
| Precision Medicine | 1 | 2022 | 102 | 0.700 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 46 | 0.690 |
Why?
|
| Glutathione | 1 | 2020 | 54 | 0.680 |
Why?
|
| Cell Communication | 1 | 2020 | 124 | 0.640 |
Why?
|
| Cell Death | 1 | 2020 | 271 | 0.640 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 147 | 0.610 |
Why?
|
| Mass Casualty Incidents | 1 | 2018 | 30 | 0.600 |
Why?
|
| Feedback, Physiological | 2 | 2015 | 59 | 0.600 |
Why?
|
| Republic of Korea | 5 | 2025 | 29 | 0.530 |
Why?
|
| Autocrine Communication | 1 | 2015 | 32 | 0.500 |
Why?
|
| Emergency Medical Services | 1 | 2018 | 255 | 0.480 |
Why?
|
| Hair Follicle | 1 | 2015 | 29 | 0.480 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 152 | 0.460 |
Why?
|
| Escherichia coli | 1 | 2019 | 695 | 0.460 |
Why?
|
| Receptors, Mating Factor | 1 | 2014 | 2 | 0.450 |
Why?
|
| Interleukin-2 | 1 | 2014 | 164 | 0.440 |
Why?
|
| Pheromones | 1 | 2014 | 22 | 0.440 |
Why?
|
| Social Behavior | 1 | 2014 | 87 | 0.420 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 428 | 0.420 |
Why?
|
| Stem Cells | 1 | 2015 | 255 | 0.410 |
Why?
|
| Motor Vehicles | 4 | 2023 | 35 | 0.410 |
Why?
|
| Glucose | 3 | 2009 | 445 | 0.390 |
Why?
|
| Models, Theoretical | 3 | 2023 | 256 | 0.370 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2010 | 19 | 0.350 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 623 | 0.350 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 99 | 0.330 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2010 | 83 | 0.330 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2014 | 425 | 0.330 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2020 | 125 | 0.330 |
Why?
|
| Signal Transduction | 3 | 2015 | 2903 | 0.320 |
Why?
|
| Thoracic Injuries | 3 | 2023 | 45 | 0.280 |
Why?
|
| Biological Transport | 2 | 2020 | 288 | 0.240 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1465 | 0.230 |
Why?
|
| Injury Severity Score | 3 | 2019 | 101 | 0.220 |
Why?
|
| Cause of Death | 1 | 2025 | 210 | 0.220 |
Why?
|
| Cell Proliferation | 2 | 2020 | 941 | 0.220 |
Why?
|
| Microbial Viability | 1 | 2023 | 57 | 0.220 |
Why?
|
| Climate Change | 1 | 2023 | 18 | 0.220 |
Why?
|
| Aged | 8 | 2025 | 13405 | 0.210 |
Why?
|
| Middle Aged | 9 | 2025 | 16310 | 0.210 |
Why?
|
| Retrospective Studies | 4 | 2025 | 6069 | 0.210 |
Why?
|
| Humans | 16 | 2025 | 59366 | 0.200 |
Why?
|
| Adult | 8 | 2025 | 15679 | 0.190 |
Why?
|
| Radius Fractures | 1 | 2021 | 8 | 0.190 |
Why?
|
| Spinal Fractures | 1 | 2021 | 36 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 62 | 0.180 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2020 | 6 | 0.180 |
Why?
|
| Transformation, Genetic | 1 | 2020 | 27 | 0.180 |
Why?
|
| G2 Phase | 1 | 2020 | 23 | 0.180 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 131 | 0.180 |
Why?
|
| Hip Fractures | 1 | 2021 | 63 | 0.180 |
Why?
|
| Genes, Fungal | 1 | 2020 | 56 | 0.170 |
Why?
|
| Mobile Applications | 1 | 2022 | 129 | 0.170 |
Why?
|
| Public Health | 1 | 2021 | 176 | 0.170 |
Why?
|
| Female | 9 | 2025 | 30719 | 0.170 |
Why?
|
| Risk Factors | 3 | 2025 | 4986 | 0.160 |
Why?
|
| Animals | 4 | 2023 | 19649 | 0.160 |
Why?
|
| Biomass | 1 | 2019 | 25 | 0.160 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 84 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2020 | 293 | 0.160 |
Why?
|
| Whiplash Injuries | 1 | 2019 | 2 | 0.160 |
Why?
|
| Air Bags | 1 | 2018 | 2 | 0.160 |
Why?
|
| Seat Belts | 1 | 2018 | 10 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 377 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2022 | 717 | 0.150 |
Why?
|
| Disaster Planning | 1 | 2018 | 48 | 0.150 |
Why?
|
| Pedestrians | 1 | 2018 | 2 | 0.150 |
Why?
|
| Male | 8 | 2025 | 27742 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 411 | 0.140 |
Why?
|
| Automobiles | 1 | 2018 | 65 | 0.140 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2017 | 14 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1304 | 0.140 |
Why?
|
| Automobile Driving | 1 | 2018 | 55 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 110 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2017 | 109 | 0.130 |
Why?
|
| Ants | 1 | 2015 | 1 | 0.130 |
Why?
|
| Acyl-Butyrolactones | 1 | 2015 | 1 | 0.130 |
Why?
|
| Aminobutyrates | 1 | 2016 | 10 | 0.130 |
Why?
|
| Ammonia | 1 | 2016 | 13 | 0.130 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2016 | 20 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 119 | 0.130 |
Why?
|
| Neoplasms | 1 | 2025 | 1231 | 0.120 |
Why?
|
| Young Adult | 3 | 2019 | 4273 | 0.120 |
Why?
|
| Abbreviated Injury Scale | 3 | 2019 | 13 | 0.110 |
Why?
|
| Infant | 1 | 2018 | 1491 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2018 | 1792 | 0.110 |
Why?
|
| Protein Transport | 1 | 2014 | 399 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1022 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 986 | 0.090 |
Why?
|
| Norfloxacin | 1 | 2010 | 2 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 36 | 0.080 |
Why?
|
| Doxycycline | 1 | 2009 | 42 | 0.080 |
Why?
|
| Game Theory | 1 | 2009 | 5 | 0.080 |
Why?
|
| Mice | 1 | 2023 | 10294 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1552 | 0.080 |
Why?
|
| Kinetics | 1 | 2009 | 751 | 0.070 |
Why?
|
| Craniocerebral Trauma | 2 | 2018 | 56 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2009 | 486 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 70 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2007 | 98 | 0.070 |
Why?
|
| Incidence | 2 | 2021 | 1238 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 205 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 213 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2019 | 814 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 734 | 0.060 |
Why?
|
| Hemothorax | 1 | 2023 | 8 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2022 | 45 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1032 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 584 | 0.050 |
Why?
|
| Logistic Models | 1 | 2023 | 1235 | 0.040 |
Why?
|
| Neck Injuries | 1 | 2018 | 19 | 0.040 |
Why?
|
| Leg Injuries | 1 | 2018 | 16 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 831 | 0.040 |
Why?
|
| Acceleration | 1 | 2018 | 36 | 0.040 |
Why?
|
| Medical Records | 1 | 2018 | 133 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5119 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2016 | 43 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 2338 | 0.030 |
Why?
|
| Seizures | 1 | 2016 | 113 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 110 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2380 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 883 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 133 | 0.030 |
Why?
|
| Echocardiography | 1 | 2017 | 457 | 0.030 |
Why?
|
| Obesity | 1 | 2021 | 1166 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1504 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 148 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1479 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 3067 | 0.020 |
Why?
|
| beta-Fructofuranosidase | 1 | 2009 | 3 | 0.020 |
Why?
|
| Competitive Behavior | 1 | 2009 | 8 | 0.020 |
Why?
|
| Diffusion | 1 | 2009 | 82 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 95 | 0.020 |
Why?
|
| Child | 1 | 2018 | 4187 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 210 | 0.020 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2007 | 5 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2007 | 44 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 23 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 40 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2007 | 65 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 46 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 5835 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 26 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2007 | 27 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 44 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2007 | 22 | 0.020 |
Why?
|
| Endodeoxyribonucleases | 1 | 2007 | 41 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 103 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 140 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 359 | 0.020 |
Why?
|
| Antioxidants | 1 | 2007 | 241 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 559 | 0.020 |
Why?
|
| Mitochondria | 1 | 2007 | 343 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 1368 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 3615 | 0.010 |
Why?
|